Ignite Creation Date:
2024-05-06 @ 7:54 AM
Last Modification Date:
2024-10-26 @ 11:53 AM
Study NCT ID:
NCT02626962
Status:
COMPLETED
Last Update Posted:
2022-03-22
First Post:
2015-12-01
Brief Title:
Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma
Sponsor:
Grupo Español Multidisciplinar de Melanoma
Organization:
Grupo Español Multidisciplinar de Melanoma
Organization Data
Organization:
Grupo Español Multidisciplinar de Melanoma
Class:
OTHER
Study ID:
GEM-1402
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Grupo Español Multidisciplinar de Melanoma
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |